|
| Status |
Public on Jul 15, 2022 |
| Title |
Effect of two compounds on HBV gene expression in HBV-infected primary human hepatocytes. |
| Organism |
Hepatitis B virus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
HBV gene expression in HBV-infected primary human hepatocytes.
|
| |
|
| Overall design |
Comparative time-series gene expression profiling analysis of HBV RNA-seq data derived from cultured primary human hepatocytes treated with two compounds, RO21 and RO22, and vehicle compounds.
|
| |
|
| Contributor(s) |
Zhang J, Adibi M, Küng E |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Jul 13, 2022 |
| Last update date |
Sep 01, 2022 |
| Contact name |
Jitao David Zhang |
| E-mail(s) |
jitao_david.zhang@roche.com
|
| Phone |
+41616886251
|
| Organization name |
F. Hoffmann-La Roche
|
| Department |
Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel
|
| Lab |
Pharmaceutical Sciences
|
| Street address |
Grenzacherstrasse 124
|
| City |
Basel |
| ZIP/Postal code |
4070 |
| Country |
Switzerland |
| |
|
| Platforms (1) |
| GPL32478 |
Illumina HiSeq 2500 (Hepatitis B virus) |
|
| Samples (96)
|
|
| Relations |
| BioProject |
PRJNA858422 |
Less...
More...